Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissues

被引:1
|
作者
Mokrzycki, Nathalie [1 ]
Delrat, Pascal [2 ]
De Meulder, Marc [3 ]
Erbach, Eva [4 ]
Lentheric, Irene [5 ]
McIntosh, Morna [6 ]
Dzygiel, Pawel [7 ]
Timmerman, Philip [3 ]
机构
[1] Labs Merck Sharp & Dohme Chibret, F-63963 Clermont Ferrand 9, France
[2] Technol SERVIER, F-45000 Orleans, France
[3] Janssen Res & Dev, B-2340 Beerse, Belgium
[4] Bayer Pharma AG Global Drug Discovery, Global Early Dev, Drug Metab & Pharmacokinet, D-13353 Berlin, Germany
[5] Harlan Labs SA, Barcelona 08130, Spain
[6] Charles River Tranent, Charles River Labs, Bioanal & Immunol, Edinburgh EH33 1NE, Midlothian, Scotland
[7] Hoffmann La Roche AG, CH-4070 Basel, Switzerland
关键词
METHOD ESTABLISHMENT; SUPPORT;
D O I
10.4155/bio.14.35
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tissue analysis has always been a difficult discipline of bioanalysis. Laboratoriesthat perform bioanalysis in tissue are facing a lot of challenges and questions before starting experiments, from a scientific/technical point of viewregarding more regulated aspects. Actually, literature is poor regarding the more technical and scientific aspects but also beyond that no clear guidance is available on this topic and laboratories performing tissue analysis face real ambiguityregarding regulatory requirements, alwayswith the risk of under- or over-validation of the assay. For all of these reasons bioanalysis in tissue became a frequently discussed topic within the European Bioanalytical Forum (EBF) organization. The EBF then decided to treat this as a specific topic, and carried out a survey that was done in two steps between 2012 and 2013. This paper represents an exhaustive summary of the result of this survey that includes themost important aspects of tissue bioanalysis. This survey provided the team a good starting point for their discussions and resulted in an EBF recommendation paper published separately.
引用
收藏
页码:1617 / 1626
页数:10
相关论文
共 50 条
  • [41] NOVEL DEVELOPMENTS IN THE BIOANALYSIS OF DRUGS
    DEZEEUW, RA
    PHARMACY INTERNATIONAL, 1983, 4 (07): : 192 - 192
  • [42] Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10-keeping our finger on the pulse
    Timmerman, Philip
    Barfield, Matthew
    Portabella, Enric Bertran
    Calogero, Salvatore
    Cowan, Kyra
    Faber, Joerg
    Ferrari, Luca
    Golob, Michaela
    Goodman, Jo
    Goodwin, Lee
    Gnoth, Mark Jean
    Hughes, Richard
    Ivanova, Tsvetelina
    Jordan, Gregor
    Lauren, Anna
    Maux, Delphine
    Mcdougall, Stuart
    Milushewa, Petya
    Nelson, Robert
    Pynaert, Gwenda
    Sklodowski, Kamil
    Sleigh, Rebecca
    Struwe, Petra
    Verhaeghe, Tom
    Wheller, Robert
    White, Steve
    Zeiser, Katja
    BIOANALYSIS, 2024, 16 (05) : 259 - 270
  • [43] Bioanalysis of new designer drugs
    Wohlfarth, Ariane
    Weinman, Wolfgang
    BIOANALYSIS, 2010, 2 (05) : 965 - 979
  • [44] NOVEL DEVELOPMENTS IN THE BIOANALYSIS OF DRUGS
    DEZEEUW, RA
    PHARMACY INTERNATIONAL, 1984, 5 (01): : 20 - 24
  • [45] European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry
    Higton, David
    Young, Graeme
    Timmerman, Philip
    Abbott, Richard
    Knutssons, Magnus
    Svensson, Leif D.
    BIOANALYSIS, 2012, 4 (22) : 2669 - 2679
  • [46] European Bioanalysis Forum recommendation on the best practices to demonstrate processed sample stability
    Wilson, Amanda
    Barker, Suzanne
    Freisleben, Achim
    Laakso, Sirpa
    Staelens, Ludovicus
    White, Steve
    Timmerman, Philip
    BIOANALYSIS, 2019, 11 (01) : 7 - 11
  • [47] The fourth China Bioanalysis Forum Annual Meeting
    Tang, Daniel
    Zhong, Dafang
    Dong, Kelly
    BIOANALYSIS, 2017, 9 (02) : 159 - 162
  • [48] New development and update on China Bioanalysis Forum
    Jin, Fan
    Tang, Daniel
    Dong, Kelly
    Zhong, Dafang
    BIOANALYSIS, 2021, 13 (04) : 199 - 201
  • [49] The challenges for implementing Good Clinical Practices in the bioanalytical laboratory: a discussion paper from the European Bioanalysis Forum
    Timmerman, Philip
    Ivanova, Tsvetelina
    Arfvidsson, Cecilia
    Barfield, Matthew
    Bove, Floris
    Brown, Lea Dalby
    Goodman, Jo
    McDougall, Stuart
    Monk, Lee
    White, Steve
    BIOANALYSIS, 2024, 16 (13) : 635 - 639
  • [50] Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories
    Arfvidsson, Cecilia
    Zeiser, Katja
    Andresen, Lars-Ole
    Van Bedaf, David
    Buddiger, Harm
    Jones, Christopher
    Schauerte, Werner
    Sigh, Jens
    Vagaday, Milan
    Timmerman, Philip
    BIOANALYSIS, 2024,